Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee

Osteoarthritis Pain Clinical Trial

Official title:
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee

Status Terminated

Clinical Trial Summary

To evaluate the efficacy of ACP-044 compared with placebo in the treatment of pain associated with osteoarthritis of the knee

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05008835
Study type	Interventional
Source	ACADIA Pharmaceuticals Inc.
Contact
Status	Terminated
Phase	Phase 2
Start date	July 20, 2021
Completion date	September 8, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01780389` - Open-label Milnacipran for Persistent Knee Pain One Year After Total Knee Arthroplasty (TKA)	Phase 4
Completed	`NCT00917696` - Study to Evaluate ATP-induced Pain and ATP-induced Dermal Vasodilation by Iontophoresis (0000-118)(COMPLETED)	Phase 1
Completed	`NCT04296344` - Group Acupuncture Therapy With Modified Yoga	N/A
Completed	`NCT01980940` - The Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Participants With Osteoarthritis (MK-0663-168)	Phase 1/Phase 2
Completed	`NCT01030640` - Study To Assess Changes In The Number Of Nerves In The Skin At The Site Where Where Tanezumab Is Injected	Phase 1